Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against the in-vitro/in-vivo model of Parkinson’s disease via modulation of GSK-3β/ Nrf2/HO-1 signaling

Publisher:
Elsevier BV
Publication Type:
Journal Article
Citation:
European Journal of Pharmacology, 2025, pp. 177523-177523
Issue Date:
2025-03
Filename Description Size
Chitosan nanoparticles_GSK_3β:_Nrf2_HO-1 signaling_Parkinson Disease.pdfPublished version20.5 MB
Adobe PDF
Full metadata record
Please use this identifier to cite or link to this item: